UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Primary culture of mouse dopaminergic neurons

Journal of visualized experiments, 2014-09 (91), p.e51751-e51751

2014

Volltextzugriff (PDF)

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (36), p.E3825-E3830

2014

Volltextzugriff (PDF)

Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease

Frontiers in aging neuroscience, 2013, Vol.5, p.96-96

2013

Volltextzugriff (PDF)

Heptahelical Domain of Metabotropic Glutamate Receptor 5 Behaves Like Rhodopsin-like Receptors

Proceedings of the National Academy of Sciences - PNAS, 2004-01, Vol.101 (1), p.378-383

2004

Volltextzugriff (PDF)

Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors

Molecular pharmacology, 2009-04, Vol.75 (4), p.982-990

2009

Volltextzugriff (PDF)

Closure of the Venus Flytrap Module of mGlu8 Receptor and the Activation Process: Insights from Mutations Converting Antagonists into Agonists

Proceedings of the National Academy of Sciences - PNAS, 2002-08, Vol.99 (17), p.11097-11102

2002

Volltextzugriff (PDF)

G Protein Activation by Serotonin Type 4 Receptor Dimers

The Journal of biological chemistry, 2011-03, Vol.286 (12), p.9985-9997

2011

Volltextzugriff (PDF)

Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia

The Journal of neuroscience, 2012-04, Vol.32 (17), p.5900

2012

Volltextzugriff (PDF)

Gα olf Mutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia

The Journal of neuroscience, 2012-04, Vol.32 (17), p.5900-5910

2012

Volltextzugriff (PDF)

Donecopride, a Swiss army knife with potential against Alzheimer's disease

British journal of pharmacology, 2020-05, Vol.177 (9), p.1988-2005

2020

Volltextzugriff (PDF)

Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease

Neuropharmacology, 2017-11, Vol.126, p.128-141

2017

Volltextzugriff (PDF)

Donecopride, a Swiss army knife with potential interest against Alzheimer's disease

British journal of pharmacology, 2020, Vol.177 (9), p.1988-2005

2020

Volltextzugriff (PDF)

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

EMBO molecular medicine, 2012-10, Vol.4 (10), p.1043-1056

2012

Volltextzugriff (PDF)

G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient

The Journal of biological chemistry, 2011-03, Vol.286 (12), p.9985-9997

2011

Volltextzugriff (PDF)

5‑HT4 Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10

ACS chemical neuroscience, 2013-01, Vol.4 (1), p.130-140

2013

Volltextzugriff (PDF)

5-Hydroxytryptamine4 Receptor Activation of the Extracellular Signal-regulated Kinase Pathway Depends on Src Activation but Not on G Protein or β-Arrestin Signaling

Molecular biology of the cell, 2007-06, Vol.18 (6), p.1979-1991

2007

Volltextzugriff (PDF)

Primary Culture of Mouse Dopaminergic Neurons

Journal of visualized experiments, 2014-09 (91)

2014

Volltextzugriff (PDF)

Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors

The Journal of biological chemistry, 2005-07, Vol.280 (30), p.27924-27934

2005

Volltextzugriff (PDF)

Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease

Neuropharmacology, 2017-11, Vol.126, p.128-141

2017

Volltextzugriff (PDF)

β-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT 4 receptor signalling

The EMBO journal, 2009-09, Vol.28 (18), p.2706-2718

2009

Volltextzugriff (PDF)

Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands: Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction

Brain research, 2013, Vol.1511, p.65-72

2013

Volltextzugriff (PDF)

β-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling

The EMBO journal, 2009-09, Vol.28 (18), p.2706-2718

2009

Volltextzugriff (PDF)

Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands

Brain research, 2013-05, Vol.1511, p.65-72

2013

Volltextzugriff (PDF)

Chapter 7 - Serotonin Type 4 Receptor Dimers

Methods in cell biology, 2013-01, Vol.117, p.123-139

2013

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(48)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Animals
(20)
Life Sciences
(18)
Life Sciences & Biomedicine
(18)
Humans
(10)
Mice
(10)
Receptors, Serotonin, 5-Ht4 - Metabolism
(9)
Neurons And Cognition
(8)
Biochemistry, Molecular Biology
(7)
Neurosciences
(7)
Neurosciences & Neurology
(7)
Pharmacology & Pharmacy
(7)
Proteins
(7)
Cell Line
(6)
Cos Cells
(6)
Ligands
(6)
Male
(6)
Mutation
(6)
Neurobiology
(6)
Pharmacology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary culture of mouse dopaminergic neurons

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease

Heptahelical Domain of Metabotropic Glutamate Receptor 5 Behaves Like Rhodopsin-like Receptors

Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors

Closure of the Venus Flytrap Module of mGlu8 Receptor and the Activation Process: Insights from Mutations Converting Antagonists into Agonists

G Protein Activation by Serotonin Type 4 Receptor Dimers

Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia

Gα olf Mutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia

Donecopride, a Swiss army knife with potential against Alzheimer's disease

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease

Donecopride, a Swiss army knife with potential interest against Alzheimer's disease

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient

5‑HT4 Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10

5-Hydroxytryptamine4 Receptor Activation of the Extracellular Signal-regulated Kinase Pathway Depends on Src Activation but Not on G Protein or β-Arrestin Signaling

Primary Culture of Mouse Dopaminergic Neurons

Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors

Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease

β-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT 4 receptor signalling

Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands: Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction

β-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling

Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands

Chapter 7 - Serotonin Type 4 Receptor Dimers

Suchergebnisse filtern